ArticleCureus2024
Reducing Postbreast Reconstruction Infection Rates: Our Journey to Achieving Low Postoperative Infection Outcomes.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Postoperative Infection After Implant-Based Breast Reconstruction: Risk Factors and Clinical Burden in a Large Single-Center Cohort.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionBreast surgeries are classified as clean procedures associated with a lower risk of post-operative infections; however, the reported infection rates post-breast surgeries are still significantly high. Surgical site infections (SSIs) are indeed one of the most common and serious complications following breast surgery. METHODOLOGY: A retrospective study assessed the rate of SSIs post-breast reconstructive surgery after the implementation of the infection control protocol at James Cook University Hospital and Friarage Hospital from December 2022 to June 2024. Initial post-operative breast reconstruction cases at James Cook University Hospital and Friarage Hospital showed a high SSI rate of 23%, with Theatre 22 in James Cook University Hospital reporting 25%, despite adherence to infection control protocols. Subsequent investigations identified Pseudomonas contamination in scrub water taps and inadequate airflow in Theatre 22 as potential sources. Corrective actions were implemented, including relocating surgeries to facilities with superior air filtration and forming a Protocol Reinforcement Team to ensure strict adherence to infection control measures and the Protocol of Breast Reconstruction Surgery (PBRS). Data was collected from the information department of James Cook University Hospital retrospectively, looking at all patients who underwent breast reconstruction procedures from December 2022 to June 2024. Patients who developed SSIs at the breast reconstruction implant site were identified by reviewing the patients' notes. The confirmed diagnosis as well as the classification and potential risk factors were identified retrospectively from the patients' notes as well. All patients included in the study were strictly adherent to the PBRS. IBM SPSS Statistics for Windows, Version 21 (Released 2012; IBM Corp., Armonk, New York, United States) was used for both descriptive and inferential analyses of the data, and no adjustments were made for multiple comparisons.
resultsAmong 31 patients (48 procedures), complications included delayed infection (n=1 procedure), drain exit site infection (n=1 procedure), skin necrosis (n=2 procedures), wound dehiscence (n=1 procedure), and seroma (n=1 procedure). We reported low infection rates to post-breast reconstruction with strict adherence to the PBRS (02.08%) in comparison to the current guidelines and published literature (up to 25%).
conclusionDespite improvements, SSIs remain a significant concern in implant-based breast reconstruction procedures. Adopting and adhering to a standardized PBRS are strongly recommended to further reduce complications and enhance patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.